20672 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Microorganisms or materials therefrom; Viruses; Subviral particles; Bacteriophages Adenovirus
MATERIALS AND METHODS FOR INCREASING IMMUNE RESPONSES
#302LIVE AND IN-VIVO TUMOR SPECIFIC CANCER VACCINE SYSTEM DEVELOPED BY CO-ADMINISTRATION OF EITHER AT LEAST TWO OR ALL THREE OF THE FOLLOWING COMPONENTS SUCH AS TUMOR CELLS, AN ONCOLYTIC VIRUS VECTOR WITH TRANSGENIC EXPRESSION OF GM-CSF AND AN IMMUNE CHECKPOINT MODULATOR
#303Adenoviruses and methods for using adenoviruses
#304Therapeutic compositions and methods of use for treating cancer
#305ANTI-ANGIOGENIC ADENOVIRUS
#306METHODS FOR THE TREATMENT OF DISEASE WITH GENE EDITING SYSTEMS
#307Regulation of RAN translation by PKR and eIF2A-P pathways
#308Oncolytic virus and method
#309Application of oncolytic viruses as immunostimulants for treatment of tumors and/or cancers
#310Compositions and methods of treatment
#311Treatment of haematological malignancies
#312ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSIDS AND METHODS OF USE THEREOF
#313CNS delivery of therapeutic agents
#314MODIFIED UBE3A GENE FOR A GENE THERAPY APPROACH FOR ANGELMAN SYNDROME
#315AAV-CRISPR/Cas9 genome editing of VEGFR2 for treating ocular diseases
#316Methods for the Delivery of Therapeutic Agents to Donor Organs
#317VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR 21 (FGF21) CODING SEQUENCE
#318METHOD FOR TREATING AN AUDITORY NEUROPATHY SPECTRUM DISORDER
#319Use of adenovirus and nucleic acids coding therefor
#320Adeno-associated virus capsid variants and methods of use thereof
#321Gene therapy for treating peroxisomal disorders
#322Mosaic chimeric viral vaccine particle
#323CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING CANCER
#324Gene therapy for ciliopathies
#325Method for Treating Ischemic Tissue
#326Methods and compositions for inducing protective immunity against RSV infection
#327Membrane lipid coated viral nanoparticles and method of use
#328Minigene therapy
#329Adeno-associated virus (AAV) clade f vector and uses therefor
#330Methods and compositions for CNS delivery of iduronate-2-sulfatase
#331METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS
#332Neural stem cell-mediated cancer treatment
#333Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases
#334Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery
#335Liver targeting adeno-associated viral vectors
#336Programmable Oncolytic Virus Vaccine System and Method
#337VIRAL DELIVERY OF NEOANTIGENS
#338METHODS AND COMPOSITIONS COMPRISING VIRAL GENE THERAPY AND AN IMMUNE CHECKPOINT INHIBITOR FOR TREATMENT AND PREVENTION OF CANCER AND INFECTIOUS DISEASES
#339Methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders
#340ONCOLYTIC VIRUS THERAPY
#341Anticancer composition comprising tumor-specific oncolytic adenovirus and immune checkpoint inhibitor
#342Detargeted adenovirus variants and related methods
#343Compositions for treatment of wet age-related macular degeneration
#344Compositions for treating conditions using recombinant self-complementary adeno-associated virus
#345Oncolytic virotherapy and immunotherapy
#346Adeno-associated virus purification methods
#347Fractal combination therapy
#348TUMOR-TARGETING BEAD VECTORS AND METHODS OF USING THE SAME
#349ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX
#350TUMOR SELECTIVE TATA-BOX AND CAAT-BOX MUTANTS
#351MULTIPLE TRANSGENE RECOMBINANT ADENOVIRUS
#352USE OF VIRAL VECTORS IN THE TREATMENT OF RETINOBLASTOMA
#353Oncolytic adenoviruses for treating cancer
#354AADC polynucleotides for the treatment of Parkinson's disease
#355THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS
#356Gene therapy for treating Phenylketonuria
#357Therapeutic agents and uses thereof for drugs for treatment of tumors and/or cancers
#358Methods and materials for treating cancer
#359PV-DELETED BOVINE ADENOVIRUS
#360Gene Therapy For Mesothelioma
#361DUAL OVERLAPPING ADENO-ASSOCIATED VIRAL VECTOR SYSTEM FOR EXPRESSING ABCA4
#362AAV capsid designs
#363Virus-PCION complex having enhanced antitumor effect by using electromagnetic field
#364AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
#365Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#366USE OF GLUCOCORTICOID ANALOGS TO ENHANCE RECOMBINANT ADENO-ASSOCIATED VIRUS YIELD
#367Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin
#368Tropic cell based virotherapy for the treatment of cancer
#369COMBINATION THERAPY FOR TREATMENT OF BRAIN CANCERS
#370OPTOGENETIC VISUAL RESTORATION USING CHRIMSON
#371BIOMARKERS AND COMBINATION THERAPIES USING ONCOLYTIC VIRUS AND IMMUNOMODULATION
#372Methods of treating cancer
#373Potent and balanced bidirectional promoter
#374ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING PAH GENE FUNCTION AND METHODS OF USE THEREOF
#375Modulation of TJP1 expression to regulate regeneration of heart cells
#376Tumor-specific adenovirus vectors and therapeutic uses
#377Adenovirus formulations
#378Adenovirus armed with bispecific T cell engager
#379A Novel Method for Stabilization of a Biopharmaceutical Drug Product During Processing
#380Combining adenovirus and checkpoint inhibitors for treating cancer
#381Adenovirus and immunomodulator combination therapy
#382Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engager
#383Methods and compositions for CNS delivery of heparan n-sulfatase
#384ONCOLYTIC ADENOVIRUSES FOR CANCER TREATMENT
#385MiR-127 agents for use in the treatment of renal fibrosis
#386Adenoviral vector
#387Compositions and methods for treating CEP290 associated disease
#388Use of MIR101 or MIR128 in the treatment of seizure disorders
#389REELIN COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISORDERS
#390PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CARTILAGE DISEASES
#391Compositions and methods useful for prophylaxis of organophosphates
#392Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Production and Use Thereof for Treatment of Cancer
#393Tumor-selective E1a and E1b mutants
#394System and Method for Managing All Cancers by Disabling the Cancer Cells Ability to Reproduce
#395Adeno-associated virus compositions for restoring HBB gene function and methods of use thereof
#396Methods and compositions for treating metabolic imbalance
#397Adeno-associated virus vector delivery of microrna-29 to treat muscular dystrophy
#398ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#399Methods of heat inactivation of adenovirus
#400Group B adenovirus encoding an anti-TCR-complex antibody or fragment
#401Oncolytic adenovirus encoding a B7 protein or active fragment
#402Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
#403Adeno-associated virus vector delivery of microRNA-29 and micro-dystrophin to treat muscular dystrophy
#404AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
#405Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy
#406Use of adenovirus and nucleic acids coding therefor
#407Treatment methods using adenovirus
#408Compositions and Methods for Treating Neuropathic Pain
#409Compositions and methods for genetically modifying myosin phosphatase target subunit (Mypt1) gene for lowering blood pressure
#410Adeno-Associated Virus Virions for Treatment of Epilepsy
#411Gene editing of deep intronic mutations
#412Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#413Modified interleukin 12 and use thereof in preparing drugs for treating tumours
#414Method using expression of LIN28 for preparing stem cells having excellent renewal ability and therapeutic capacity
#415Means and methods for AAV gene therapy in humans
#416COMBINING ADENOVIRUS AND CHEMOTHERAPEUTIC AGENTS FOR TREATING CANCER
#417TDP-43 in degenerative disease
#418Oncolytic adenoviruses with increased proportion of the 156R splicing isoform of the E1B protein
#419Composition for treatment of Crigler-Najjar syndrome
#420PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CARDIAC FIBROSIS
#421Virus encoding an anti-TCR-complex antibody or fragment
#422ONCOLYTIC RHABDOVIRUS
#423Compositions and methods for viral delivery of neoepitopes and uses thereof
#424Viral vector targeting cancer stem cells
#425Compositions and methods for enhanced gene expression in cone cells
#426METHODS OF TREATING SOLID OR LYMPHATIC TUMORS BY COMBINATION THERAPY
#427TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS
#428Oncolytic adenoviruses armed with heterologous genes
#429Modulation of AAV vector transgene expression
#430Targeted cancer therapy
#431Adenovirus complex for gene delivery and gene iherapy
#432METHODS FOR PREVENTING PLASTIC-INDUCED DEGRADATION OF BIOLOGICALS
#433Methods for inducing an immune response
#434Composition for intracellular delivery containing adenovirus protein VI-derived peptide and anticancer pharmaceutical composition containing same
#435METHODS OF TREATING PARKINSON'S DISEASE USING VIRAL VECTORS
#436Adenovirus forumations
#437Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration
#438COMPOSITIONS AND METHODS FOR ACHIEVING HIGH LEVELS OF TRANSDUCTION IN HUMAN LIVER CELLS
#439NOVEL ADENOVIRUS
#440Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#441Products and Methods for Delivery of Polynucleotides by Adeno-Associated Virus for Lysosomal Storage Disorders
#442Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same
#443Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the peripheral nervous system of a subject
#444Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
#445NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS CONTAINING A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN) OR FRAGMENT THEREOF
#446Anti-tumor medicament based on adenovirus
#447Compositions and methods for treating cancer
#448Oncolytic adenoviruses with mutations in immunodominant adenovirus epitopes and their use in cancer treatment
#449SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS
#450Oncolytic adenovirus encoding a B7 protein
#451Treatment of ocular neovascularization using anti-VEGF proteins
#452Immune modulator for immunotherapy and vaccine formulation
#453VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER
#454THERAPEUTIC COMPOSITIONS AND METHODS OF USE FOR TREATING CANCER
#455Detargeted adenovirus variants and related methods
#456Engineered oncolytic viruses containing hyper-binding sites to sequester and suppress activity of oncogenic transcription factors as a novel treatment for human cancer
#457Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety
#458Combination immunotherapy for treating cancer
#459Oncolytic virus formulation and preparation method thereof
#460Methods and compositions for CNS delivery of arylsulfatase A
#461Prevention and/or treatment of hearing loss or impairment
#462Oncolytic adenovirus encoding a B7 protein
#463METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS
#464Use of adenovirus and nucleic acids coding therefor
#465Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein
#466Multitargeting onocolytic adenovirus, methods of use, and methods of making
#467ADENOVIRUS CONSTRUCTS AND METHODS
#468LncRNA and oncolytic adenovirus, and application thereof
#469Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#470Oncolytic adenovirus encoding a therapeutic protein or active fragment
#471Virus-PCION complex having enhanced antitumor effect by using electromagnetic field
#472Methods for reversing multiple resistance in animal cells
#473SMC combination therapy for the treatment of cancer
#474ONCOLYTIC TUMOR VIRUSES AND METHODS OF USE
#475Conditionally replicating adenovirus to express REIC gene
#476Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof
#477AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
#478Enhanced adoptive cell therapy
#479Ph-sensitive and bioreducible polymer-virus complex for cancer treatment
#480Targeted adenoviruses and methods of making, isolating, and using
#481Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#482PPSA and Pspa polymer-virus complex and pharmaceutical compositions comprising the same
#483PROCESS FOR THE PREPARATION OF GROUP B ADENOVIRUSES
#484Oncolytic adenovirus encoding a B7 protein or active fragment
#485Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin
#486Adenovirus comprising an albumin-binding moiety
#487CNS delivery of therapeutic agents
#488In vivo Gene Engineering with Adenoviral Vectors
#489Group B adenovirus modified in the E4orf4 region
#490Oncolytic adenoviruses for cancer treatment
#491Polynucleotides, vectors and methods for insertion and expression of transgenes
#492Oncolytic adenoviruses armed with heterologous genes
#493Tropic cell based virotherapy for the treatment of cancer
#494Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)
#495Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#496In vivo individualized systemic immunotherapeutic method and device
#497Puma protein expression vector and use thereof in gene therapy
#498Regulating calcium in excitable cells with a novel protein
#499Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same
#500Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#501Adenovirus formulations
#502TREATMENT METHODS USING ADENOVIRUS
#503TREATMENT OF BRAIN CANCER WITH ONCOLYTIC ADENOVIRUS
#504Delivery of a therapeutic agent to the cerebral cortex by administering a viral vector by convection enhanced diffusion into the white matter of the brain
#505Dosing regime and formulations for type B adenovirus
#506Use of a truncated CCN1 promoter for cancer diagnostics, therapeutics and theranostics
#507Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof
#508RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORS
#509Use of adenoviruses and nucleic acids that code for said viruses
#510Simian Subfamily B Adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and Uses Thereof
#511NANOPARTICLE FABRICATION METHODS, SYSTEMS, AND MATERIALS
#512Adeno-associated virus variants and methods of use thereof
#513TUMOR-SELECTIVE E1A AND E1B MUTANTS
#514Oncolytic adenovirus compositions
#515Recombinant adenovirus with increased safety and anticancer activities, and use thereof
#516Oncolytic adenoviruses with increased proportion of the 156R splicing isoform of the E1B protein
#517Immune modulator for immunotherapy and vaccine formulation
#518Therapy for radiation-induced lung injury
#519Oncolytic adenovirus armed with therapeutic genes
#520Compositions and methods for enhanced gene expression in cone cells
#521ONCOLYTIC VIRUS ENCODING PD-1 BINDING AGENTS AND USES OF THE SAME
#522Enhanced adoptive cell therapy
#523Recombinant serotype 5 (Ad5) adenoviral vectors
#524Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#525Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#526MYOSTATIN INHIBITION FOR ENHANCING MUSCLE AND/OR IMPROVING MUSCLE FUNCTION
#527Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#528FAS-chimera adenovirus vector
#529Chimeric adenoviruses for use in cancer treatment
#530Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#531Selective cell targeting using adenovirus and chemical dimers
#532Treatment of ocular neovascularization using anti-VEGF proteins
#533Biomarkers and combination therapies using oncolytic virus and immunomodulation
#534Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#535TREATMENT OF AMD USING AAV SFLT-1
#536COMBINATION OF ONCOLYTIC ADENOVIRUSES WITH HISTONE DEACETYLASE INHIBITORS
#537METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC SYNDROME, OBSTRUCTIVE RESPIRATORY DISORDERS, CANCER AND RELATED DISEASES
#538RECOMBINANT ADENOVIRUS COMPRISING TRANS-SPLICING RIBOZYME AND CANCER-TREATING GENE, AND USE THEREOF
#539Peptides that target dorsal root ganglion neurons
#540Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#541AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
#542Uniform field magnetization and targeting of therapeutic formulations
#543REIC-expressing adenovirus vector
#544Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same
#545BI-Specific Diabodies For Masking And Targeting Vaccines
#546ONCOLYTIC RHABDOVIRUS
#547VIRAL VECTOR TARGETING CANCER STEM CELLS
#548RECOMBINANT ADENOVIRUS EXPRESSING ALPHA-A-CRYSTALLIN GENE AND GENE THERAPY FOR RETINALVASCULAR DISEASE USING THE SAME
#549Transfection of Mesothelium Body Cavity Lining with Gene Agents Followed by Chemotharapy to Treat Cancer of Organs in the Body Cavity
#550Use of CD83 in combination therapies
#551Oncolytic rhabdovirus
#552Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#553TREATMENT OF AMD USING AAV SFLT-1
#554PRODUCTS AND METHODS FOR DELIVERY OF POLYNUCLEOTIDES BY ADENO-ASSOCIATED VIRUS FOR LYSOSOMAL STORAGE DISORDERS
#555Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence
#556Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof
#557Hexon Tat-PTD modified adenovirus and uses thereof
#558Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase
#559Virus clearance of neoplastic cells from mixed cellular compositions
#560Anti-cancer adenoviruses
#561Chimeric adenoviruses for use in cancer treatment
#562Chimeric adenoviruses for use in cancer treatment
#563COMPOSITIONS OF RECOMBINANT HUMAN ENDOSTATIN ADENOVIRUS INJECTIONS AND METHODS OF PRODUCTION
#564Chimeric adenoviruses for use in cancer treatment
#565Excipients for Stabilising Viral Particles, Polypeptides or Biological Material
#566HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS-BASED VACCINES
#567Recombinant Adenovirus Having Anti-Angiogenesis Activity
#568Methods of treating Parkinson's disease using viral vectors
#569Uniform field magnetization and targeting of therapeutic formulations
#570Pharmaceutical kit and method for treating cancer
#571Tumor specific promoter and oncolytic virus vector comprising the same
#572PRODUCTS AND METHODS FOR DELIVERY OF POLYNUCLEOTIDES BY ADENO-ASSOCIATED VIRUS FOR LYSOSOMAL STORAGE DISORDERS
#573Uniform Field Magnetization and Targeting of Therapeutic Formulations
#574Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#575Compositions and methods for treatment of cancer using tissue-specific oncolytic adenoviruses
#576METHOD AND COMPOSITION FOR CREATING CONDITIONAL LETHALITY FOR VIRUS MUTANTS AND FOR ELIMINATING THE VIABILITY OF AN EUKARYOTIC CELL
#577Method and Composition to Increase Radiation-Induced Tumor Therapeutic Effects
#578Chimeric adenoviruses for use in cancer treatment
#579INFECTIVITY-ENHANCED CONDITIONALLY-REPLICATIVE ADENOVIRUS AND USES THEREOF
#580THERAPEUTIC REGIMEN FOR TREATING CANCER
#581MICROBUBBLE ASSISTED VIRAL DELIVERY
#582Viruses for the treatment of cellular proliferative disorders
#583Oncolytic adenoviruses for treating cancer
#584Attenuated strain of myxoma virus for use as an oncolytic drug
#585HUMAN MATRIX METALLOPROTEINASE-8 GENE DELIVERY ENHANCES THE ONCOLYTIC ACTIVITY OF A REPLICATING ADENOVIRUS
#586NON-AD5 ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#587CNS delivery of therapeutic agents
#588Tumor selective E1a and E1b mutants
#589METHODS FOR REVERSING MULTIPLE RESISTANCE IN ANIMAL CELLS
#590Multivalent vaccines comprising recombinant viral vectors
#591NOVEL USE OF ADENOVIRUSES AND NUCLEIC ACIDS THAT CODE FOR SAID VIRUSES
#592Multivalent vaccines comprising recombinant viral vectors
#593REPLICATION COMPETENT VIRUSES CAPABLE OF SILENCING VIRUS INHIBITORY FACTOR EXPRESSION
#594Virus clearance of neoplastic cells from mixed cellular compositions
#595Peptides that target dorsal root ganglion neurons
#596Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator
#597Promoter and viral vector containing the same
#598Adenoviruses Mutated In The VA Genes For Cancer Treatment
#599Oncolytic rhabdovirus
#600Infectivity-enhanced conditionally-replicative adenovirus and uses thereof